XVIVO PERFUSION AB U/ADR (XVIPY)
News Quantified tracks XVIPY headlines — 45 labeled events over the last three years — but too few produced usable price reactions to publish stable medians. The events themselves are below.
Not enough usable reactions to publish XVIPY medians.
45 XVIPY events are labeled, but too few carry a measurable price reaction for a median to mean anything. When enough reactions accumulate, the medians publish here the same way as every other name.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when XVIPY moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to XVIPY's baseline. Nothing else.
Recent XVIPY events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Conference call on Interim Report July-September 2026 | Press release | ACCESS Newswire | — | — | |
| Nomination Committee of XVIVO Perfusion AB (publ) | Press release | ACCESS Newswire | — | +0.00% | |
| XVIVO Announces FDA Receipt of PMA Application for The XVIVO Heart Assist Transport System | Press release | ACCESS Newswire | — | — | |
| XVIVO Receives CE Certificates for Its Groundbreaking Heart Preservation Technology, Transforming Access to Life-Saving Transplants Across Europe | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport | Press release | ACCESS Newswire | — | — | |
| Interim Report January - June 2026 | Press release | ACCESS Newswire | — | — | |
| Conference call on Interim Report April-June 2026 | Press release | ACCESS Newswire | — | — | |
| Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology | Press release | ACCESS Newswire | — | — | |
| Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ) | Press release | ACCESS Newswire | — | — | |
| Interim Report January - March 2026 | Press release | ACCESS Newswire | — | — | |
| Late-Breaking Data from PRESERVE Trial Evaluates XVIVO’s HOPE Preservation Approach in Heart Transplantation | Press release | Business Wire | — | — | |
| Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO's Heart Technology Presented at ISHLT in Toronto | Press release | ACCESS Newswire | — | — | |
| XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation | Press release | ACCESS Newswire | — | — | |
| Conference Call on Interim Report January-March 2026 | Press release | ACCESS Newswire | — | — | |
| The 12-Month Follow-up Results from XVIVO's European Multicenter Heart Trial is Now Published in the European Heart Journal | Press release | ACCESS Newswire | — | — | |
| Annual Report 2025 | Press release | ACCESS Newswire | — | — | |
| Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ) | Press release | ACCESS Newswire | — | — | |
| CORRECTION FROM SOURCE: The Nomination Committee's Proposal for New Board Members | Press release | ACCESS Newswire | — | — | |
| The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors | Press release | ACCESS Newswire | — | — | |
| Management Change at XVIVO - CFO Transitions to New Role | Press release | ACCESS Newswire | — | — | |
| Change of Date for Publication of the Interim Report January-March 2026 | Press release | ACCESS Newswire | — | — | |
| Year-End Report 2025 | Press release | ACCESS Newswire | — | — | |
| Conference Call on Year-End Report 2025 | Press release | ACCESS Newswire | — | — | |
| XVIVO's CEO to present at J.P. Morgan's 44th Annual Healthcare Conference in San Francisco | Press release | ACCESS Newswire | — | — | |
| Interim Report January-September 2024 | Press release | Accesswire | — | — | |
| Conference Call on Interim Report | Press release | Accesswire | — | — | |
| XVIVO to Acquire a Unique Communication Platform for the Transplant Process | Press release | Accesswire | — | +0.00% | |
| Nomination Committee of XVIVO Perfusion AB (publ) | Press release | Accesswire | — | — | |
| Results From European Randomized Controlled Study Using XVIVO's Heart Technology Published in The Lancet | Press release | Accesswire | +0.00% | +0.00% | |
| Interim Report January - June 2024 | Press release | Accesswire | — | — | |
| Conference call on Interim Report | Press release | Accesswire | — | — | |
| Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ) | Press release | Accesswire | — | — | |
| Interim report January-March 2024 | Press release | Accesswire | — | — | |
| Results from XVIVO’s Clinical Trial NIHP2019 for Heart Preservation Presented at ISHLT in Prague | Press release | Accesswire | — | — | |
| Conference call on Interim Report | Press release | Accesswire | — | — | |
| Annual Report 2023 | Press release | Accesswire | — | — | |
| Notice to Attend The Annual General Meeting in XVIVO Perfusion AB (PUBL) | Press release | Accesswire | — | — | |
| The First-Ever Transplantation with a Donor Heart Transported Across the Atlantic Ocean - Made Possible by the use of XVIVO’s Heart Technology | Press release | Accesswire | — | — | |
| XVIVO Presents Report on Operations 2023 | Press release | Accesswire | — | — | |
| Extended Perfusion Time of Livers Can Streamline Planning and Logistics - Enabling More Liver Transplants to be Performed During Daytime | Press release | Accesswire | — | — | |
| Conference Call on Report on Operations 2023 | Press release | Accesswire | — | — | |
| XVIVO Reaches Milestone in Italy: 1,200 Lifesaving Perfusions Performed with Liver Assist | Press release | Accesswire | — | — | |
| XVIVO Announces a Write-Down Related to PrimECC of SEK 17 Million Not Affecting Cashflow or EBITDA | Press release | Accesswire | — | — | |
| Results from a Australian/New Zealand study using XVIVO’s Heart Technology Published | Press release | Accesswire | — | — | |
| Interim Report January-September 2023 | Press release | Accesswire | — | — | |
| Leading Academic Medical Center Performs First Heart Transplant in the U.S. Utilizing NIHP Technology as Part of XVIVO's PRESERVE Clinical Trial | Press release | Accesswire | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the XVIPY section they belong to.
Where else XVIPY is measured.
XVIPY earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.